Subscribe to our newsletter
KSM is proud to announce the presentation of our latest study at the European Lung Cancer Congress (ELCC) 2026 in Copenhagen.
The research introduces a Machine Learning model capable of predicting Non-Small Cell Lung Cancer (NSCLC) risk up to 6 months prior to clinical detection, with a 90.2% AUC. Despite travel constraints due to the security situation in Israel, our findings were shared with the global oncology community, highlighting KSM’s commitment to saving lives through data-driven innovation—no matter the obstacles.
